InsiderTrades

Form 4 for MRNA Moderna

Accepted 2021-11-23 00:00:00 ET · period of report 2021-11-19 · accession 0000899243-21-045849 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-11-23 2021-11-19+ MRNA Andres Juan See remarks M - OptEx $13.21 +20.0K 15.0K New +$264.3K
DM 2021-11-23 2021-11-19+ MRNA Andres Juan See remarks S - Sale+OE $267.56 -20.0K 0 -100% -$5.35M
DM 2021-11-23 2021-11-19+ MRNA Andres Juan See remarks M - OptEx $0.00 -20.0K 90.0K -18% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-19 M A 5,000 $12.21 5,000 D — —
2 Common Common Stock 2021-11-19 S D 5,000 $265.71 0 D — —
3 Common Common Stock 2021-11-22 M A 10,000 $14.22 10,000 D — —
4 Common Common Stock 2021-11-22 M A 5,000 $12.21 15,000 D — —
5 Common Common Stock 2021-11-22 S D 15,000 $268.18 0 D — —
6 Derivative Stock Option (Right to Buy) 2021-11-22 M D 5,000 $0.00 85,000 D $12.21 · — to 2027-08-29 5,000 Common Stock (F2) This option is fully vested and exercisable.
7 Derivative Stock Option (Right to Buy) 2021-11-22 M D 10,000 $0.00 48,629 D $14.22 · — to 2028-02-28 10,000 Common Stock (F3) 25% of this option will vest and become exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.
8 Derivative Stock Option (Right to Buy) 2021-11-19 M D 5,000 $0.00 90,000 D $12.21 · — to 2027-08-29 5,000 Common Stock (F2) This option is fully vested and exercisable.